Work

Results of a Phase 1b/2 Study of ATYR1940 in adolescents and young adults with early onset facioscapulohumeral muscular dystrophy (FSHD) (ATYR1940-C-003)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Neuromuscular Disorders

DOI: 10.1016/j.nmd.2017.06.381

Authors: G. Walker, R. Butterfield, K. Mathews, L. Servais, J. Day, T. Gidaro, S. Shukla, L. Maggi

Institutions: aTyr Pharma (United States), University of Iowa, Institut de Myologie, Stanford University, Fondazione IRCCS Istituto Neurologico Carlo Besta

Language: English

Topic: Muscle Physiology and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2754015013

FWCI: 0.447

Cites:

Cited by: 7

Related to: 10